Restasis and Ranitidine drug interactions - a phase IV clinical study of FDA data
Drug interactions are reported among 449 people who take Restasis and Ranitidine. Common interactions include abdominal pain among females, and renal failure among males.
The phase IV clinical study analyzes what interactions people who take Restasis and Ranitidine have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
449 people who take Restasis and Ranitidine together, and have interactions are studied.
What is Restasis?
Restasis has active ingredients of cyclosporine. It is used in dry eyes. Currently, eHealthMe is studying from 33,622 Restasis users.
What is Ranitidine?
Ranitidine has active ingredients of ranitidine. It is used in gastroesophageal reflux disease. Currently, eHealthMe is studying from 232,433 Ranitidine users.
Number of Restasis and Ranitidine reports submitted per year:
Restasis and Ranitidine drug interactions by gender *:
Restasis and Ranitidine drug interactions by age *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Restasis and Ranitidine?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
Drug side effects by duration, gender and age:
Common Restasis drug interactions:
- Restasis and Vitamin d: 3,188 reports
- Restasis and Aspirin: 3,016 reports
- Restasis and Synthroid: 2,586 reports
- Restasis and Prednisone: 2,390 reports
- Restasis and Omeprazole: 2,268 reports
- Restasis and Gabapentin: 2,186 reports
- Restasis and Methotrexate: 1,981 reports
- Restasis and Fish oil: 1,925 reports
- Restasis and Calcium: 1,813 reports
- Restasis and Vitamin d3: 1,761 reports
Browse interactions between Restasis and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Ranitidine drug interactions:
- Ranitidine and Zantac: 90,811 reports
- Ranitidine and Ranitidine hydrochloride: 21,753 reports
- Ranitidine and Aspirin: 12,047 reports
- Ranitidine and Omeprazole: 11,356 reports
- Ranitidine and Prednisone: 10,832 reports
- Ranitidine and Furosemide: 9,918 reports
- Ranitidine and Lisinopril: 8,656 reports
- Ranitidine and Gabapentin: 8,272 reports
- Ranitidine and Pantoprazole: 7,977 reports
- Ranitidine and Amlodipine: 7,769 reports
Browse interactions between Ranitidine and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
How the study uses the data?
The study uses data from the FDA. It is based on cyclosporine and ranitidine (the active ingredients of Restasis and Ranitidine, respectively), and Restasis and Ranitidine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Restasis and Ranitidine.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Mirena and Ceftriaxone drug interaction - 16 seconds ago
- Vitamin D and Udenyca drug interaction - 22 seconds ago
- Etodolac and Hydrocortisone Butyrate drug interaction - 28 seconds ago
- Omeprazole and Beta Haemolytic Streptococcal Infection - 35 seconds ago
- Amlodipine and Eysuvis drug interaction - 40 seconds ago
- Tranexamic Acid and Pepcid drug interaction - 50 seconds ago
- Decadron and Surgery - 52 seconds ago
- Fluorouracil and Unasyn drug interaction - 56 seconds ago
- Lamivudine and Injection Site Pain - 58 seconds ago
- Spironolactone and Green Tea drug interaction - 59 seconds ago